The 2025 MEA MedTech Regulatory Summit: A New Era of Collaboration and Innovation

In an exciting development for the medical technology (MedTech) sector, Mecomed and the Regulatory Affairs Professionals Society (RAPS) have joined forces to host the inaugural 2025 MEA MedTech Regulatory Summit. Scheduled for 30 January 2025 at the voco Dubai in Dubai, UAE, this one-day interactive summit promises to be a pivotal event for regulatory professionals, industry leaders, and stakeholders across the Middle East and Africa (MEA) region.

A Growing MedTech Hub

The MEA region is rapidly emerging as a diverse and dynamic hub for MedTech innovation and regulatory affairs. Rami Rajab, Chief Executive Officer of Mecomed, emphasizes the region’s potential, stating, “The Middle East and Africa encompass a growing and diverse MedTech hub in the regulatory community, with rapidly expanding new business opportunities.” As companies seek to broaden their global reach, the demand for education, professional development, and meaningful networking opportunities has never been greater.

The summit aims to address the complexities of navigating international regulations, which have become a strategic imperative for businesses looking to thrive in this evolving landscape. Rajab highlights the importance of accelerating the implementation of regulatory reliance, which is crucial for enhancing patient care and supporting industry growth.

Target Audience and Objectives

Designed specifically for senior decision-makers and regulators within the medical device community, the 2025 MEA MedTech Regulatory Summit will provide a platform for regulatory professionals to stay informed and adept in a time of rapid change. The summit will facilitate focused discussions on pressing issues and challenges that impact the region, ensuring that attendees are equipped with the knowledge and tools necessary to navigate the complexities of the regulatory environment.

Key Topics of Discussion

The summit will cover a wide array of topics that are critical to the MedTech community. Participants can expect in-depth discussions on:

• The Changing Regulatory Landscape: Insights into the evolving regulatory frameworks in the Middle East, Africa, Europe, and North America.
• Impact of AI and Software: Exploration of how artificial intelligence and software innovations are reshaping regulatory operations and practices.
• Health Authority Updates: Current updates from health authorities that will inform strategic planning and regulatory compliance.
• Global Regulatory Strategies: Discussions on the development and implementation of effective global regulatory strategies.

These topics are designed to foster collaboration and innovation, providing attendees with actionable insights that can be applied within their organizations.

Expert Planning Committee

The summit’s program has been meticulously curated by a committee of experts from across the MedTech community. This diverse group includes:

• Dr. Bassil Akra, Founder/Executive Consultant, AKRA TEAM
• Carol Attieh, Growth Emerging Markets (GEM) Regulatory Lead, Boston Scientific Middle East FZ LLC
• Rana Chalhoub, Regulatory Affairs Director, Mecomed
• Nataliya Deych, Vice President Regulatory Affairs EMEA, LATAM, Canada, Edwards Life Sciences
• Brian Savoie, Senior Vice President, Education & International Programs, RAPS
• Peter Schroeer, Vice President Regulatory Affairs EMEA and Canada, Johnson & Johnson
• Graeme Tunbridge, Senior Vice President Global Regulatory and Quality, Medical Devices, BSI

Their collective expertise ensures that the summit will feature high-quality discussions and valuable knowledge exchange.

A Call to Action

Registration for the 2025 MEA MedTech Regulatory Summit is now open, and interested participants are encouraged to secure their spots early. The complete program agenda and speaker line-up will be announced in the coming weeks, promising an event rich in insights and opportunities for collaboration.

For more information and to register, visit www.meamedtech.org.

Conclusion

The 2025 MEA MedTech Regulatory Summit represents a significant milestone in the collaboration between Mecomed and RAPS, aimed at fostering innovation and driving regulatory strategies for success in the MEA region. As the MedTech landscape continues to evolve, this summit will serve as a vital platform for stakeholders to come together, share knowledge, and shape the future of regulatory affairs in the medical technology sector. Don’t miss the opportunity to be part of this transformative event!